600332 白云山
已收盘 02-06 15:00:00
资讯
新帖
简况
白云山：阿法骨化醇软胶囊通过仿制药一致性评价
南方财经网 · 17:21
白云山：阿法骨化醇软胶囊通过仿制药一致性评价
白云山（600332）披露截至2026年1月31日证券变动月报表，2月4日股价上涨0.91%
证券之星 · 02-04 17:25
白云山（600332）披露截至2026年1月31日证券变动月报表，2月4日股价上涨0.91%
白云山（600332）披露广药广开创业投资基金完成私募基金备案暨关联交易进展公告，2月2日股价下跌0.59%
证券之星 · 02-02
白云山（600332）披露广药广开创业投资基金完成私募基金备案暨关联交易进展公告，2月2日股价下跌0.59%
白云山(00874)：子公司《药品生产许可证》变更
智通财经 · 02-02
白云山(00874)：子公司《药品生产许可证》变更
白云山、广州数字科技集团成立医药数智科技公司
人民财讯 · 01-30
白云山、广州数字科技集团成立医药数智科技公司
每周股票复盘：白云山（600332）现360万元大宗交易
证券之星 · 01-25
每周股票复盘：白云山（600332）现360万元大宗交易
1月22日白云山现360万元大宗交易
证券之星 · 01-22
1月22日白云山现360万元大宗交易
每周股票复盘：1月14日白云山（600332）发生大宗交易成交243.97万元
证券之星 · 01-18
每周股票复盘：1月14日白云山（600332）发生大宗交易成交243.97万元
1月14日白云山发生1笔大宗交易 成交金额243.97万元
证券之星 · 01-14
1月14日白云山发生1笔大宗交易 成交金额243.97万元
白云山：公司始终以研发创新作为重点发展战略之一
证券日报 · 01-12
白云山：公司始终以研发创新作为重点发展战略之一
每周股票复盘：白云山（600332）H股与A股股份及股本均无变动
证券之星 · 01-11
每周股票复盘：白云山（600332）H股与A股股份及股本均无变动
LSV Asset Management增持白云山(00874)3万股 每股作价约18.11港元
智通财经网 · 01-07
LSV Asset Management增持白云山(00874)3万股 每股作价约18.11港元
每周股票复盘：白云山（600332）注射用头孢呋辛钠通过一致性评价
证券之星 · 01-02
每周股票复盘：白云山（600332）注射用头孢呋辛钠通过一致性评价
白云山附属企业广药二期基金正式签约设立广药荔湾基金
中金财经 · 01-01
白云山附属企业广药二期基金正式签约设立广药荔湾基金
白云山：2025年第三次临时股东会决议公告
证券日报 · 2025-12-30
白云山：2025年第三次临时股东会决议公告
白云山(00874)：附属广药二期基金与广药资本、广开基金订立设立广药广开基金的合伙协议一
智通财经 · 2025-12-29
白云山(00874)：附属广药二期基金与广药资本、广开基金订立设立广药广开基金的合伙协议一
白云山最新公告：分公司白云山制药总厂注射用头孢呋辛钠通过仿制药一致性评价
证券之星 · 2025-12-29
白云山最新公告：分公司白云山制药总厂注射用头孢呋辛钠通过仿制药一致性评价
每周股票复盘：白云山（600332）子公司获狂犬病疫苗注册证
证券之星 · 2025-12-28
每周股票复盘：白云山（600332）子公司获狂犬病疫苗注册证
白云山最新公告：旗下生物制品公司获冻干人用狂犬病疫苗注册证书
证券之星 · 2025-12-25
白云山最新公告：旗下生物制品公司获冻干人用狂犬病疫苗注册证书
白云山：第九届董事会第三十二次会议决议公告
证券日报 · 2025-12-22
白云山：第九届董事会第三十二次会议决议公告
加载更多
公司概况
公司名称：
广州白云山医药集团股份有限公司
所属行业：
医药制造业
上市日期：
2001-02-06
主营业务：
广州白云山医药集团股份有限公司的主营业务是中西成药、化学原料药、天然药物、生物医药、化学原料药中间体的研发、制造与销售；西药、中药和医疗器械的批发、零售和进出口业务；大健康产品的研发、生产与销售；医疗服务、健康管理、养生养老等健康产业投资。公司的主要产品是中成药、化学药。
发行价格：
9.80
{"stockData":{"symbol":"600332","market":"SH","secType":"STK","nameCN":"白云山","latestPrice":25.61,"timestamp":1770361201000,"preClose":25.55,"halted":0,"volume":23872081,"delay":0,"changeRate":0.0023,"floatShares":1406000000,"shares":1626000000,"eps":1.837,"marketStatus":"已收盘","change":0.06,"latestTime":"02-06 15:00:00","open":25.95,"high":26.03,"low":25.61,"amount":616000000,"amplitude":0.0164,"askPrice":25.62,"askSize":80,"bidPrice":25.61,"bidSize":207,"shortable":0,"etf":0,"ttmEps":1.837,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":5,"adr":0,"adjPreClose":25.55,"symbolType":"stock","openAndCloseTimeList":[[1770341400000,1770348600000],[1770354000000,1770361200000]],"highLimit":28.11,"lowLimit":23,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1625790949,"isCdr":false,"pbRate":1.1,"roa":"--","peRate":13.941208,"roe":"8.88%","epsLYR":1.744,"committee":0.02726,"marketValue":41637000000,"turnoverRate":0.017,"status":0,"hkstockBrief":{"symbol":"00874","market":"HK","secType":"STK","nameCN":"白云山","latestPrice":19.31,"timestamp":1770365284003,"preClose":19.11,"halted":0,"volume":3293000,"delay":0,"premium":"-33.05"},"floatMarketCap":36005000000},"requestUrl":"/m/hq/s/600332","defaultTab":"news","newsList":[{"id":"2609566490","title":"白云山：阿法骨化醇软胶囊通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2609566490","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609566490?lang=zh_cn&edition=full","pubTime":"2026-02-06 17:21","pubTimestamp":1770369709,"startTime":"0","endTime":"0","summary":"南财智讯2月6日电，白云山公告，控股子公司广州白云山星群（药业）股份有限公司收到国家药监局核准签发的《药品补充申请批准通知书》，阿法骨化醇软胶囊通过仿制药质量和疗效一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602063644175641.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00874","BK0028","BK1515","BK0012","BK0239","BK1191","BK1521","BK1606","BK1197","BK0196","BK0188","BK0097","600332","BK0096","BK0175","BK0183","BK0070"],"gpt_icon":0},{"id":"2608193354","title":"白云山（600332）披露截至2026年1月31日证券变动月报表，2月4日股价上涨0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608193354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608193354?lang=zh_cn&edition=full","pubTime":"2026-02-04 17:25","pubTimestamp":1770197107,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，白云山报收于25.4元，较前一交易日上涨0.91%，最新总市值为412.95亿元。该股当日开盘25.15元，最高25.42元，最低25.12元，成交额达2.95亿元，换手率为0.83%。公司于近日披露《证券变动月报表》，公告日期为2026年2月4日。报表显示，截至2026年1月31日，公司H股和A股的法定/注册股本、已发行股份及库存股份数目均无变动。H股于香港联交所上市，A股于上交所上市，两类股份的上月底结存与本月底结存一致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400029321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK1191","BK0239","BK0183","BK0028","600332","00874","BK0070","BK0196","BK1521","BK0012","161027","BK1606","BK0097","BK0188","BK0175","BK1515","BK1197"],"gpt_icon":0},{"id":"2608081867","title":"白云山（600332）披露广药广开创业投资基金完成私募基金备案暨关联交易进展公告，2月2日股价下跌0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608081867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608081867?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:38","pubTimestamp":1770043101,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，白云山报收于25.1元，较前一交易日下跌0.59%，最新总市值为408.07亿元。近日，广州白云山医药集团股份有限公司发布公告，其附属企业参与设立的广州广药广开创业投资基金合伙企业已于2026年1月30日在中国证券投资基金业协会完成备案，取得私募投资基金备案证明，备案编码SBPR72，管理人为广州广药资本私募基金管理有限公司，托管人为招商银行股份有限公司。该基金首期实缴出资总额为1.2亿元，其中广药二期基金出资9,750万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200039450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1521","00874","600332","BK1515","BK1606","BK0188","BK0070","BK1191","BK0012","BK0096","BK1197","BK0175","BK0196","BK0028","BK0239","BK0183","BK0097"],"gpt_icon":0},{"id":"2608863092","title":"白云山(00874)：子公司《药品生产许可证》变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2608863092","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608863092?lang=zh_cn&edition=full","pubTime":"2026-02-02 19:39","pubTimestamp":1770032352,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山(00874)发布公告，近日，公司子公司广州白云山奇星药业有限公司(简称“奇星药业”)收到广东省药品监督管理局核准签发的《药品生产许可证》，同意奇星药业委托广州白云山医药集团股份有限公司白云山制药总(简称“白云山制药总厂”)厂生产虚汗停颗粒(无糖型)在原委托生产地址基础上，新增受托生产地址。本次奇星药业委托白云山制药总厂生产虚汗停颗粒(无糖型)在原委托生产地址基础上，新增受托生产地址，有利于其增加产能，提高生产效率，满足市场需求。本次获得《药品生产许可证》，对本公司当期业绩无重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400693.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0188","BK1515","BK0183","BK0028","600332","BK0239","BK0096","BK1197","BK0196","BK0175","BK1521","BK1606","BK0070","BK0097","BK0012","00874"],"gpt_icon":0},{"id":"2607062667","title":"白云山、广州数字科技集团成立医药数智科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2607062667","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607062667?lang=zh_cn&edition=full","pubTime":"2026-01-30 11:37","pubTimestamp":1769744231,"startTime":"0","endTime":"0","summary":"人民财讯1月30日电，企查查APP显示，近日，广州医药数智科技有限公司成立，注册资本3000万元，经营范围包含网络与信息安全软件开发；数据处理服务；大数据服务；人工智能应用软件开发等。企查查股权穿透显示，该公司由白云山(600332)、广州数字科技集团有限公司全资子公司广州数字健康科技有限公司共同持股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601303636718667.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","159938","BK0097","600332","09939","BK0096","BK0196","BK1515","BK1606","BK1521","BK0028","BK0183","BK0070","BK0239","BK0175","BK0012","00874","BK1574","BK1191","BK0188","BK1197"],"gpt_icon":0},{"id":"2606237303","title":"每周股票复盘：白云山（600332）现360万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2606237303","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606237303?lang=zh_cn&edition=full","pubTime":"2026-01-25 03:32","pubTimestamp":1769283133,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，白云山（600332）报收于25.32元，较上周的25.07元上涨1.0%。本周，白云山1月23日盘中最高价报25.37元。1月19日盘中最低价报25.0元。白云山当前最新总市值411.65亿元，在中药板块市值排名5/67，在两市A股市值排名519/5182。本周关注点交易信息汇总：1月22日白云山现3600万元大宗交易交易信息汇总1月22日白云山现360万元大宗交易以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500001275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1606","BK0028","BK0175","BK0183","BK0239","BK1521","BK0070","BK0012","BK1191","BK0188","600332","00874","BK1197","BK0096","BK0097","BK0196","BK1515"],"gpt_icon":0},{"id":"2605464950","title":"1月22日白云山现360万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2605464950","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605464950?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:44","pubTimestamp":1769075060,"startTime":"0","endTime":"0","summary":"证券之星消息，1月22日白云山发生大宗交易，交易数据如下：大宗交易成交价格24元，相对当日收盘价折价4.91%，成交15万股，成交金额360万元，买方营业部为民生证券股份有限公司北京第一分公司，卖方营业部为中泰证券股份有限公司杭州湖墅南路证券营业部。近三个月该股共发生4笔大宗交易，合计成交6066.0手，折价成交1笔。截至2026年1月22日收盘，白云山报收于25.24元，上涨0.12%，换手率0.57%，成交量8.01万手，成交额2.02亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200029417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK0183","BK1197","BK0097","600332","BK0012","BK0070","00874","BK0175","BK0196","BK0239","BK1191","BK0028","BK0096","BK0188","BK1606","BK1521"],"gpt_icon":0},{"id":"2604925389","title":"每周股票复盘：1月14日白云山（600332）发生大宗交易成交243.97万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604925389","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604925389?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:40","pubTimestamp":1768678816,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，白云山（600332）报收于25.07元，较上周的25.32元下跌0.99%。本周，白云山1月13日盘中最高价报25.52元。1月14日盘中最低价报25.0元。白云山当前最新总市值407.59亿元，在中药板块市值排名5/67，在两市A股市值排名500/5183。本周关注点交易信息汇总：1月14日白云山发生1笔大宗交易，成交金额243.97万元交易信息汇总1月14日白云山发生1笔大宗交易，成交金额243.97万元以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001053.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK0096","BK1197","BK0183","BK1191","BK0012","BK0239","00874","600332","BK0097","BK0188","BK1521","BK1606","BK0196","BK0028","BK0070","BK0175"],"gpt_icon":0},{"id":"2603918706","title":"1月14日白云山发生1笔大宗交易 成交金额243.97万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603918706","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603918706?lang=zh_cn&edition=full","pubTime":"2026-01-14 17:33","pubTimestamp":1768383222,"startTime":"0","endTime":"0","summary":"证券之星消息，1月14日白云山发生大宗交易，交易数据如下：大宗交易成交价格25.1元，成交9.72万股，成交金额243.97万元，买方营业部为东方证券股份有限公司上海黄浦区中华路证券营业部，卖方营业部为东方证券股份有限公司上海黄浦区中华路证券营业部。近三个月该股共发生3笔大宗交易，合计成交4566.0手。截至2026年1月14日收盘，白云山报收于25.1元，下跌0.79%，换手率1.55%，成交量21.84万手，成交额5.51亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400029791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1521","00874","600332","BK1515","BK1606","BK0188","BK0070","BK1191","BK0012","BK0096","BK1197","BK0175","BK0196","BK0028","BK0239","BK0183","BK0097"],"gpt_icon":0},{"id":"2602510441","title":"白云山：公司始终以研发创新作为重点发展战略之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510441","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602510441?lang=zh_cn&edition=full","pubTime":"2026-01-12 21:06","pubTimestamp":1768223170,"startTime":"0","endTime":"0","summary":"证券日报网讯1月12日，白云山在互动平台回答投资者提问时表示，公司始终以研发创新作为重点发展战略之一。目前在研1类创新药有十余项，公司已披露的在研项目主要有选择性RET小分子抑制剂BYS10片、用于膝骨关节炎的BYS30颗粒、养阴舒肝颗粒、LBZ-18、LBZ-18口服乳等，具体内容可查阅公司已披露的相关公告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601123616044971.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1606","BK0097","BK1197","BK1521","00874","BK1515","600332","BK0183","BK0028","BK0012","BK0096","BK0196","BK0070","BK1191","BK0175","BK0239","BK0188"],"gpt_icon":0},{"id":"2602053588","title":"每周股票复盘：白云山（600332）H股与A股股份及股本均无变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2602053588","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602053588?lang=zh_cn&edition=full","pubTime":"2026-01-11 02:17","pubTimestamp":1768069027,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，白云山报收于25.32元，较上周的25.74元下跌1.63%。本周关注点公司公告汇总：H股与A股股份及股本均无变动公司公告汇总：库存股数目为零公司公告汇总H股公告广州白云山医药集团股份有限公司截至2025年12月31日的证券变动月报表显示，公司普通股H股和A股的法定/注册股本、已发行股份及库存股份数目均无变动。H股上月底结存及本月底结存均为219,900,000股，A股上月底结存及本月底结存均为1,405,890,949股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0070","BK0097","BK0196","BK1521","BK0175","BK1515","BK1197","BK1191","BK0183","600332","00874","399300","159982","BK0096","BK0012","BK0188","BK1606"],"gpt_icon":0},{"id":"2601246872","title":"LSV Asset Management增持白云山(00874)3万股 每股作价约18.11港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601246872","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601246872?lang=zh_cn&edition=full","pubTime":"2026-01-07 18:56","pubTimestamp":1767783399,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，1月5日，LSV Asset Management增持白云山(00874)3万股，每股作价18.112港元，总金额约为54.34万港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260107/20260107185713_55074.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260107/20260107185713_55074.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389964.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["600332","BK0028","BK0096","BK0183","BK0239","BK0175","BK0012","BK0188","BK0196","BK1191","BK0097","BK1606","BK1197","BK1521","00874","BK1515","BK0070"],"gpt_icon":0},{"id":"2600354810","title":"每周股票复盘：白云山（600332）注射用头孢呋辛钠通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2600354810","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600354810?lang=zh_cn&edition=full","pubTime":"2026-01-02 02:03","pubTimestamp":1767290590,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，白云山报收于25.87元，较上周的25.72元上涨0.58%。本周，白云山12月23日盘中最高价报25.95元。近日，相关方已正式签署《合伙协议》，内容较此前公告无变更。广州白云山医药集团股份有限公司于2025年12月30日召开2025年第三次临时股东会，审议通过上述两项议案。该基金尚需办理工商注册登记及中国证券投资基金业协会登记备案手续，实施过程存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1197","BK1191","BK1515","BK1521","BK0239","BK0175","BK0097","BK0012","BK0183","BK0096","BK0196","BK0028","BK0070","00874","BK0188","BK1606","600332"],"gpt_icon":0},{"id":"2600887000","title":"白云山附属企业广药二期基金正式签约设立广药荔湾基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2600887000","media":"中金财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600887000?lang=zh_cn&edition=full","pubTime":"2026-01-01 10:35","pubTimestamp":1767234911,"startTime":"0","endTime":"0","summary":"中访网数据 广州白云山医药集团股份有限公司于2025年12月31日发布公告，披露其附属企业广州广药二期基金股权投资合伙企业参与投资设立广州荔湾广药创业投资基金合伙企业的进展。根据公告，广药二期基金已与广州广药资本私募基金管理有限公司、广州天使投资母基金创业投资合伙企业及广州市荔湾区产业投资基金合伙企业正式签署《合伙协议》，标志着该投资基金进入实质设立阶段。根据此前董事会决议，广药二期基金的投资金额为9,950万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260101/31909956.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["00874","BK0175","BK1521","BK1515","BK0239","BK0097","BK0196","BK0188","BK1191","BK1606","BK0183","BK0028","BK1197","BK0096","BK0070","600332","BK0012"],"gpt_icon":0},{"id":"2595479215","title":"白云山：2025年第三次临时股东会决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2595479215","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595479215?lang=zh_cn&edition=full","pubTime":"2025-12-30 20:39","pubTimestamp":1767098381,"startTime":"0","endTime":"0","summary":"证券日报网讯12月30日，白云山发布公告称，公司2025年12月30日召开2025年第三次临时股东会，审议通过《关于广州医药股份有限公司开展应收账款资产证券化业务的议案》《关于募集资金投资项目结项及节余募集资金永久补充流动资金的议案》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512303605922236.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1606","BK0028","BK0175","BK0183","BK0239","BK1521","BK0070","BK0012","BK1191","BK0188","600332","00874","BK1197","BK0096","BK0097","BK0196","BK1515"],"gpt_icon":0},{"id":"2595784972","title":"白云山(00874)：附属广药二期基金与广药资本、广开基金订立设立广药广开基金的合伙协议一","url":"https://stock-news.laohu8.com/highlight/detail?id=2595784972","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595784972?lang=zh_cn&edition=full","pubTime":"2025-12-29 19:02","pubTimestamp":1767006161,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山(00874)发布公告，就有关本公司附属企业广药二期基金参与设立广药广开基金和广药荔湾基金的相关事宜。于2025年12月29日，广药二期基金与广药资本、广开基金订立了有关设立广药广开基金的合伙协议一。合伙协议一于同日正式生效，合伙协议一的主要条款并无任何变更。截至本公告日期，有关设立广药荔湾基金的合伙协议二尚未正式签署。本公司将根据香港上市规则的规定于合伙协议二签署后另行刊发公告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386641.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1521","BK0028","BK0012","BK0183","BK0096","BK0239","600332","00874","BK0175","BK1191","BK1515","BK0188","BK1606","BK0097","BK0196","BK1197","BK0070"],"gpt_icon":0},{"id":"2595784352","title":"白云山最新公告：分公司白云山制药总厂注射用头孢呋辛钠通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2595784352","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595784352?lang=zh_cn&edition=full","pubTime":"2025-12-29 18:49","pubTimestamp":1767005395,"startTime":"0","endTime":"0","summary":"白云山公告称，公司分公司白云山制药总厂收到国家药品监督管理局签发的《药品补充申请批准通知书》，注射用头孢呋辛钠及注射用头孢呋辛钠通过仿制药质量和疗效一致性评价，并同意相关变更。头孢呋辛钠为第二代头孢菌素，临床广泛用于治疗呼吸道感染、泌尿系统感染及外科感染。该药品被列入国家基本药物目录和国家医保乙类品种。白云山制药总厂已投入研发费用约1,042.10万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900026894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK0012","BK0096","BK0239","00874","BK0097","BK0196","BK0188","BK0175","01477","BK1606","BK1197","600332","BK0070","BK0183","BK1521","BK1191","BK1574","BK0028"],"gpt_icon":0},{"id":"2594247109","title":"每周股票复盘：白云山（600332）子公司获狂犬病疫苗注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2594247109","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594247109?lang=zh_cn&edition=full","pubTime":"2025-12-28 05:25","pubTimestamp":1766870713,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，白云山报收于25.87元，较上周的25.72元上涨0.58%。子公司广州白云山生物制品股份有限公司收到国家药品监督管理局核准签发的冻干人用狂犬病疫苗药品注册证书。该疫苗用于预防狂犬病，注册分类为预防用生物制品，药品批准文号有效期至2030年12月21日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001465.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0070","BK0196","BK0239","BK1606","BK1515","BK0096","BK1191","BK0183","159646","00874","600332","BK1197","BK1521","BK0028","BK0188","BK0012","BK0175"],"gpt_icon":0},{"id":"2594681236","title":"白云山最新公告：旗下生物制品公司获冻干人用狂犬病疫苗注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2594681236","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594681236?lang=zh_cn&edition=full","pubTime":"2025-12-25 17:50","pubTimestamp":1766656209,"startTime":"0","endTime":"0","summary":"白云山(600332.SH)公告称，公司合并报表范围内企业白云山生物收到国家药品监督管理局核准签发的冻干人用狂犬病疫苗（Vero细胞）的《药品注册证书》。该疫苗用于预防狂犬病，白云山生物已投入约2.05亿元研发费用。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500026903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK1191","BK1197","BK1606","BK1515","159646","BK0175","BK0097","BK0028","BK1521","BK0070","600332","BK0012","BK0096","BK0239","BK0183","BK0188","00874"],"gpt_icon":0},{"id":"2593343821","title":"白云山：第九届董事会第三十二次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2593343821","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593343821?lang=zh_cn&edition=full","pubTime":"2025-12-22 21:40","pubTimestamp":1766410803,"startTime":"0","endTime":"0","summary":"证券日报网讯12月22日晚间，白云山发布公告称，公司第九届董事会第三十二次会议审议通过《关于本公司2026年度日常关联交易预计数的议案》等多项议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512223598566472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["600332","BK0188","BK0096","BK0175","BK1191","00874","BK1197","BK1515","BK1521","BK0012","BK0196","BK0028","BK0183","BK0239","BK0070","BK1606","BK0097"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770374989224,"stockEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0158},{"period":"3month","weight":-0.0466},{"period":"6month","weight":-0.0277},{"period":"1year","weight":-0.0244},{"period":"ytd","weight":-0.0074}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":-0.0019},{"period":"3month","weight":0.0196},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.2621},{"period":"ytd","weight":0.027}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州白云山医药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2001-02-06","address":"广东省广州市荔湾区沙面北街45号","registeredCapital":"162579万元","survey":" 广州白云山医药集团股份有限公司的主营业务是中西成药、化学原料药、天然药物、生物医药、化学原料药中间体的研发、制造与销售；西药、中药和医疗器械的批发、零售和进出口业务；大健康产品的研发、生产与销售；医疗服务、健康管理、养生养老等健康产业投资。公司的主要产品是中成药、化学药。","listedPrice":9.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"白云山(600332)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供白云山(600332)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"白云山,600332,白云山股票,白云山股票老虎,白云山股票老虎国际,白云山行情,白云山股票行情,白云山股价,白云山股市,白云山股票价格,白云山股票交易,白云山股票购买,白云山股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"白云山(600332)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供白云山(600332)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}